1.Chiu WT, Tran TV, Pan SC, Huang HK, Chen YC, Wong TW. Cystic Fibrosis Transmembrane Conductance Regulator: A Possible New Target for Photodynamic Therapy Enhances Wound Healing. Adv Wound Care (New Rochelle). 2019;8(10):476–86. Doi: 10.1089/wound.2018.0927.
2.Parker-McGill K, Nugent M, Bersie R, Hoffman G, Rock M, Baker M, et al. Changing incidence of cystic fibrosis in Wisconsin, USA. Pediatr Pulmonol. 2015;50(11):1065–72. Doi: 10.1002/ppul.23265.
3.Hangul M, Pekcan S, Kose M, Acican D, Sahlar TE, Erdogan M, et al. The Incidence of Cystic Fibrosis in the Central Region of Anatolia in Turkey Between 2015 and 2016. Balkan Med J. 2019;36(3):179–83. Doi: 10.4274/balkanmedj.galenos.2018.2018.1332.
4.Papas KA, Sontag MK, Pardee C, Sokol RJ, Sagel SD, Accurso FJ, et al. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis. J Cyst Fibros. 2008;7(1):60–7. Doi: 10.1016/j.jcf.2007.05.001.
5.Kleme ML, Levy E. Cystic fibrosis-related oxidative stress and intestinal lipid disorders. Antioxid Redox Signal. 2015;22(7):614–31. Doi: 10.1089/ars.2014.6012.
6.Kalivianakis M, Minich DM, Bijleveld CM, van Aalderen WM, Stellaard F, Laseur M, et al. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr. 1999;69(1):127–34. Doi: 10.1093/ajcn/69.1.127.
7.Perrem L, Stanojevic S, Solomon M, Carpenter S, Ratjen F. Incidence and risk factors of paediatric cystic fibrosis-related diabetes. J Cyst Fibros. 2019. Doi: 10.1016/j.jcf.2019.04.015.
8.Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000;162(3 Pt 1):891–5. Doi: 10.1164/ajrccm.162.3.9904075.
9.Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, et al. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros. 2007;6(2):101–9. Doi: 10.1016/j.jcf.2006.03.009.
10.Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation—mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012;32(8):1771–6. Doi: 10.1161/atvbaha.111.241869.
11.Nichols DP, Chmiel JF. Inflammation and its genesis in cystic fibrosis. Pediatr Pulmonol. 2015;50 Suppl 40:S39–56. Doi: 10.1002/ppul.23242.
12.Quinton PM. Cystic fibrosis: lessons from the sweat gland. Physiology (Bethesda). 2007;22:212–25. Doi: 10.1152/physiol.00041.2006.
13.Cantin AM, Hartl D, Konstan MW, Chmiel JF. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy. J Cyst Fibros. 2015;14(4):419–30. Doi: 10.1016/j.jcf.2015.03.003.
14.Ziai S, Coriati A, Gauthier MS, Rabasa-Lhoret R, Richter MV. Could T cells be involved in lung deterioration and hyperglycemia in cystic fibrosis? Diabetes Res Clin Pract. 2014;105(1):22–9. Doi: 10.1016/j.diabres.2014.03.002.
15.Buyken AE, Goletzke J, Joslowski G, Felbick A, Cheng G, Herder C, et al. Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies. Am J Clin Nutr. 2014;99(4):813–33. Doi: 10.3945/ajcn.113.074252.
16.Hu Y, Block G, Norkus EP, Morrow JD, Dietrich M, Hudes M. Relations of glycemic index and glycemic load with plasma oxidative stress markers. Am J Clin Nutr. 2006;84(1):70–6; quiz 266–7. Doi: 10.1093/ajcn/84.1.70.
17.Rouhani MH, Kelishadi R, Hashemipour M, Esmaillzadeh A, Surkan PJ, Keshavarz A, et al. The Impact of a Low Glycemic Index Diet on Inflammatory Markers and Serum Adiponectin Concentration in Adolescent Overweight and Obese Girls: A Randomized Clinical Trial. Horm Metab Res. 2016;48(4):251–6. Doi: 10.1055/s–0042–100467.
18.Esfahani A, Wong JM, Mirrahimi A, Srichaikul K, Jenkins DJ, Kendall CW. The glycemic index: physiological significance. J Am Coll Nutr. 2009;28 Suppl:439s–45s. Doi:
19.Gilbertson HR, Brand-Miller JC, Thorburn AW, Evans S, Chondros P, Werther GA. The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes. Diabetes Care. 2001;24(7):1137–43. Doi: 10.2337/diacare.24.7.1137.
20.Jarvi AE, Karlstrom BE, Granfeldt YE, Bjorck IE, Asp NG, Vessby BO. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care. 1999;22(1):10–8. Doi: 10.2337/diacare.22.1.10.
21.Jenkins DJ, Kendall CW, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL, et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. Jama. 2008;300(23):2742–53. Doi: 10.1001/jama.2008.808.
22.Markovic TP, Muirhead R, Overs S, Ross GP, Louie JC, Kizirian N, et al. Randomized Controlled Trial Investigating the Effects of a Low-Glycemic Index Diet on Pregnancy Outcomes in Women at High Risk of Gestational Diabetes Mellitus: The GI Baby 3 Study. Diabetes Care. 2016;39(1):31–8. Doi: 10.2337/dc15–0572.
23.Ojo O, Ojo OO, Wang XH, Adegboye ARA. The Effects of a Low GI Diet on Cardiometabolic and Inflammatory Parameters in Patients with Type 2 and Gestational Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Nutrients. 2019;11(7). Doi: 10.3390/nu11071584.
24.Juanola-Falgarona M, Salas-Salvado J, Ibarrola-Jurado N, Rabassa-Soler A, Diaz-Lopez A, Guasch-Ferre M, et al. Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: a randomized controlled trial. Am J Clin Nutr. 2014;100(1):27–35. Doi: 10.3945/ajcn.113.081216.
25.Lai HC, Kosorok MR, Laxova A, Davis LA, FitzSimmon SC, Farrell PM. Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics. 2000;105(1 Pt 1):53–61. Doi: 10.1542/peds.105.1.53.
26.Karabulut S, Afsar CU, Karabulut M, Alis H, Kilic L, Cikot M, et al. Evaluation of Serum Interleukin–17 (IL–17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma. J Gastrointest Cancer. 2016;47(1):47–54. Doi: 10.1007/s12029–015–9787-z.
27.Lusman S, Sullivan J. Nutrition and Growth in Cystic Fibrosis. Pediatr Clin North Am. 2016;63(4):661–78. Doi: 10.1016/j.pcl.2016.04.005.
28.Azadbakht L, Mohammadifard N, Akhavanzanjani M, Taheri M, Golshahi J, Haghighatdoost F. The association between dietary glycemic index, glycemic load and diet quality indices in Iranian adults: results from Isfahan Healthy Heart Program. Int J Food Sci Nutr. 2016;67(2):161–9. Doi: 10.3109/09637486.2015.1134443.
29.Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76(1):5–56. Doi: 10.1093/ajcn/76.1.5.
30.De Rougemont A, Normand S, Nazare JA, Skilton MR, Sothier M, Vinoy S, et al. Beneficial effects of a 5-week low-glycaemic index regimen on weight control and cardiovascular risk factors in overweight non-diabetic subjects. Br J Nutr. 2007;98(6):1288–98. Doi: 10.1017/s0007114507778674.
31.Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066–73. Doi: 10.1126/science.2475911.